SEC Form 4 · accession 0001104659-18-070829
Amphastar Pharmaceuticals, Inc. · AMPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard K Prins
Director
Period of report
Nov 29, 2018
Accepted (ET)
Nov 30, 2018 · 4:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001297184
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 29, 2018 | M | 5,000 | $14.66 | A | 40,434 | D | |
| Common Stock | Nov 29, 2018 | S | 5,000 | $20.50 | D | 35,434 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $14.66 | Nov 29, 2018 | M | 5,000 | D | — | Dec 20, 2018 | Common Stock | 5,000 | 0 | D |
Explanation of responses
- F1Shares subject to the option are fully vested and immediately exercisable.